What is the current Global Viral Vector and Plasmid DNA Manufacturing Market size?

In 2024, the Global Viral Vector and Plasmid DNA Manufacturing Market size is expected to reach USD 1.82 billion. Read More

Who are the key players in Global Viral Vector and Plasmid DNA Manufacturing Market?

Fujifilm Diosynth Biotechnologies, SIRION Biotech, Thermo Fisher Scientific, Merck KGaA Inc. and Cognate BioServices Inc. (Cobra Biologics) are the major companies operating in the Global Viral Vector and Plasmid DNA Manufacturing Market. Read More

Which is the fastest growing region in Global Viral Vector and Plasmid DNA Manufacturing Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Viral Vector and Plasmid DNA Manufacturing Market?

In 2024, the North America accounts for the largest market share in Global Viral Vector and Plasmid DNA Manufacturing Market. Read More

What years does this Global Viral Vector and Plasmid DNA Manufacturing Market cover, and what was the market size in 2023?

In 2023, the Global Viral Vector and Plasmid DNA Manufacturing Market size was estimated at USD 1.43 billion. The report covers the Global Viral Vector and Plasmid DNA Manufacturing Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Viral Vector and Plasmid DNA Manufacturing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Viral Vector and Plasmid DNA Manufacturing Market Share

Q: How big is the Global Viral Vector and Plasmid DNA Manufacturing Market?

The Global Viral Vector and Plasmid DNA Manufacturing Market size is expected to reach USD 1.82 billion in 2024 and grow at a CAGR of 27.18% to reach USD 6.05 billion by 2029. Read More

Statistics for the 2023 & 2024 Global Viral Vector and Plasmid DNA Manufacturing market share, created by Mordor Intelligence™ Industry Reports. Global Viral Vector and Plasmid DNA Manufacturing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Viral Vector and Plasmid DNA Manufacturing Industry

The market is still in the nascent stage. Hence, increasing focus is mainly on the development of innovative products. Key market players include Cobra Biologics, Fujifilm Diosynth Biotechnologies, SIRION Biotech, Merck KGaA Inc., and Thermo Fisher Scientific.

Various strategies, such as research and development, mergers and acquisitions, and product launches, are being adopted by domestic companies to strengthen their market position. In December 2020, CHA Biotech signed a lease agreement with Matica Bio to construct a viral vector production facility in College Station, Texas. The construction of the 25,000 sq. ft facility started in Q4 2020. It is expected to be dedicated to producing viral vectors used in cell and gene therapies, vaccines, and oncolytic products. It was scheduled to open in Q3 2021.